News | Computed Tomography (CT) | November 23, 2015

CIRS Whole Body and Organ Dose Phantoms for Radiation Therapy

dosimetry phantoms

CIRS ATOM phantoms are a full line of anthropomorphic, cross sectional dosimetry phantoms designed to investigate organ dose, whole body effective dose as well as verification of delivery of therapeutic radiation doses.

ATOM is the only line of dosimetry phantoms to range in sizes from newborn to adult. Six models are available: newborn, 1-year, 5-year and 10-year old pediatric phantoms as well as adult male and female phantoms.

Each phantom is sectional in design with traditional 25 mm thick sections. The sectional surfaces are extremely flat and smooth and do not require any special coatings or treatment. This results in minimal interfaces between the slabs when viewed in a scout or projection X-ray. The ATOM line also differs from other dosimetry phantoms by providing optimized TLD locations specific to 21 inner organs.

Tissue-equivalent epoxy resins are used in all aspects of the phantom. CIRS technology offers superior tissue simulation Dosimetry Verification Phantoms by covering a wider range of energy levels from diagnostic to therapeutic. In addition, all bones are homogeneous and are formulated to represent age appropriate, average bone composition. CIRS bone formulations offer distinct advantages over natural skeletons and other types of simulated bone. 

  • Phantom models cover a wide range of patient ages
  • Organ specific dosimetry with minimal detectors
  • Superior tissue simulation and lifelike imaging properties
  • Homogeneous bone
  • Accommodates wide variety of detectors
  • Age appropriate references

This product or an optional accessory of this product requires a CIRS dosimetry cavity code before an order can be placed. Please refer to the Dosimetry Cavity Codes document to identify the CIRS code for the probe you intend to use with this product.

For more information: www.cirsinc.com


Related Content

News | Computed Tomography (CT)

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) ...

Home February 02, 2026
Home
News | Computed Tomography (CT)

Jan. 6, 2026 — Cleerly, a leader in AI-based cardiovascular imaging, has announced that Aetna will begin covering ...

Home January 07, 2026
Home
News | Computed Tomography (CT)

Dec. 2, 2025 — At RSNA 2025, Siemens Healthineers announced Syngo.CT Coronary Cockpit1, a new software solution within ...

Home December 03, 2025
Home
News | Computed Tomography (CT)

Nov. 18, 2025 — Harrison.ai has launched its CE-marked CT Chest solution, a comprehensive AI tool that assists ...

Home November 18, 2025
Home
News | Computed Tomography (CT)

Sept. 30, 2025 — Biograph and Caristo Diagnostics have announced a partnership for Biograph to become the first U.S ...

Home October 02, 2025
Home
News | Computed Tomography (CT)

Sept. 29, 2025 — Many studies have shown the inverse relationship between bone mineral density (BMD) — the gold standard ...

Home September 30, 2025
Home
News | Computed Tomography (CT)

June 30, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD), will present new data ...

Home July 08, 2025
Home
News | Computed Tomography (CT)

May 19, 2025 - Arineta, a provider of cardiovascular imaging solutions, recently announced that its SpotLight Duo ...

Home May 19, 2025
Home
News | Computed Tomography (CT)

Mar. 28, 2025 — At the American College of Cardiology (ACC) 2025 meeting, GE HealthCare will introduce Revolution Vibe,i ...

Home March 28, 2025
Home
News | Computed Tomography (CT)

March 11, 2025 — Caristo Diagnostics has received U.S. Food and Drug Administration (FDA) 510(k) clearance of its CaRi ...

Home March 11, 2025
Home
Subscribe Now